Indivior (INDV)

 

Latest News

Additional RBP-6000 Clinical Study Results

RNS Number: 7411A Indivior PLC 28 March 2017 Indivior Announces Additional Results from Clinical Studies Further Supporting the Relationship Between Sustained Plasma Levels of Buprenorphine as Delivered by RBP-6000 Monthly Depot, High Levels of -Opioid Receptor Occupancy in the Brain, and Clinical Efficacy Results also include preliminary health econ...

Indivior sets date for AGM

Indivior has confirmed that the Annual General Meeting of the Company is scheduled to be held at 3.00pm on Wednesday...

Annual Financial Report

RNS Number: 3055A Indivior PLC 23 March 2017 Indivior PLC ('Indivior' or the 'Company') Annual Report and Accounts for the year ended December 31, 2016 ('Annual Report & Accounts 2016') and Annual General Meeting 2017 ('AGM') The Company has today posted or made available to shareholders the following documents: Annual Report & Accounts 2016; Not...

Top-line Phase 3 Trial Results - RBP-7000

RNS Number: 2769Z Indivior PLC 13 March 2017 Indivior PLC Announces Positive Top-line 12-Month Phase 3 Results Confirming Long-Term Safety Profile of RBP-7000 in Patients with Schizophrenia Results represent the first demonstration of safety and durability of effect for a once-monthly injectable form of subcutaneously-administered risperidone in a long-t...

All News

DateHeadlineSource
28-03-17Additional RBP-6000 Clinical Study ResultsRNS
23-03-17Indivior sets date for AGMStockMarketWire
23-03-17Annual Financial ReportRNS
13-03-17Top-line Phase 3 Trial Results - RBP-7000RNS
13-03-17Broker Forecast - RBC Capital Markets issues a broker note on Indivior PlcStockMarketWire
08-03-17Indivior CFO steps down StockMarketWire
07-03-17Director ResignationRNS
02-03-17Broker Forecast - Citigroup issues a broker note on Indivior PlcStockMarketWire
27-02-17Director Deals - Indivior Plc (INDV)StockMarketWire
27-02-17Director Deals - Indivior Plc (INDV)StockMarketWire
27-02-17Director Deals - Indivior Plc (INDV)StockMarketWire
27-02-17Director Deals - Indivior Plc (INDV)StockMarketWire
27-02-17Director Deals - Indivior Plc (INDV)StockMarketWire
27-02-17Director Deals - Indivior Plc (INDV)StockMarketWire
27-02-17Director Deals - Indivior Plc (INDV)StockMarketWire
27-02-17Director Deals - Indivior Plc (INDV)StockMarketWire
27-02-17Director/PDMR ShareholdingRNS
27-02-17Director/PDMR ShareholdingRNS
27-02-17Broker Forecast - Jefferies International issues a broker note on Indivior PlcStockMarketWire
22-02-17Indivior net revenues rise StockMarketWire
22-02-17Directorate ChangeRNS
22-02-17Full Year Financial ResultsRNS
15-02-17Director DeclarationRNS
14-02-17Holding(s) in CompanyRNS
13-02-17Holding(s) in CompanyRNS
10-02-17Holding(s) in CompanyRNS
09-02-17Holding(s) in CompanyRNS
06-02-17Indivior schedules FY resultsStockMarketWire
06-02-17Notice of ResultsRNS
03-02-17Indivior names Mark Crossley as new CFOStockMarketWire
03-02-17Director DeclarationRNS
03-02-17Broker Forecast - Cantor Fitzgerald issues a broker note on Indivior PlcStockMarketWire
01-02-17Total Voting RightsRNS
24-01-17Indivior strengthens its board StockMarketWire
24-01-17Directorate ChangeRNS
09-01-17Indivior CEO to present at JP Morgan conference StockMarketWire
09-01-17JP Morgan Healthcare ConferenceRNS
23-12-16Holding(s) in CompanyRNS
15-12-16Broker Forecast - Jefferies International issues a broker note on Indivior PlcStockMarketWire
09-12-16Research & Development Day in New YorkRNS

RSS feeds

  • Editorial news feed for LSE:INDV Editorial
  • Regulatory news feed for LSE:INDV Regulatory